Technologies

Creative Biolabs Advances Integrated Target and TME Workflows to Accelerate Pancreatic Cancer Immunotherapy Research

  • by

Creative Biolabs, a senior provider in biotechnology and life sciences, today announced an enhancement to its specialized oncology research portfolio. Shirley, New York, United States, May 26, 2026 — By integrating high-affinity antibodies targeting Epithelial-Mesenchymal… Read More »Creative Biolabs Advances Integrated Target and TME Workflows to Accelerate Pancreatic Cancer Immunotherapy Research